Young Breast Cancer Cohort Study

Samsung Medical Center2,000 enrolled

Overview

This study is prospective cohort study to investigate and identify comprehensively the clinicopathological features and long-term outcome of young breast cancer (YBC). We have enrolled Breast cancer patients under 40 year-old and collected their baseline characteristics including tumor character, familiar history and other background information. Moreover, we have collected breast cancer tissue/blood sample for analyzing genetic characteristics, if patient agree to genetic analysis.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Breast Cancer

Eligibility

Sex: FEMALEMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Diagnosis with breast cancer 2. Age under 40 year-old or diagnosis with breast cancer at pregnancy or within 1year after delivery 3. Obtained informed consent form Exclusion Criteria: 1\) Cannot understand or disagree to informed consent form

Locations (1)

Samsung Medical Center

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

Progression free survival

Time to detect disease recurrence from surgery date

Time frame: From date of surgery until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 60 months

Central Contacts

Yeon Hee Park, MD

CONTACT

82-2-3410-1780 yhparkhmo@skku.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.